Dave Stassen is a founding Managing Director of Split Rock Partners, an early stage venture capital firm with $975 million under management.
Stassen focuses on investments in Minnesota¹s medical technology industry. Previously, he served as CEO of Spine-Tech, from formation through acquisition for over $600 million. His investments include Anulex, Atritech, Cayenne Medical, Evalve, K spine, Sonoma Orthopedics, Tornier, Transcend Medical and Zyga Technologies.